Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,191 | -31,793 | -21,386 | -13,575 | -6,140 |
| Depreciation Amortization | 43 | 148 | 110 | 77 | 43 |
| Other Working Capital | 933 | 1,684 | 2,304 | 1,930 | 731 |
| Other Operating Activity | -969 | 4,738 | 1,162 | 771 | 325 |
| Operating Cash Flow | $-7,184 | $-25,222 | $-17,811 | $-10,797 | $-5,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -226 | -108 | -101 | -30 |
| Investing Cash Flow | $N/A | $-226 | $-108 | $-101 | $-30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 9,611 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $9,611 | $N/A | $0 | $0 |
| Beginning Cash Position | 19,866 | 35,704 | 35,704 | 35,704 | 35,704 |
| End Cash Position | 12,683 | 19,866 | 17,785 | 24,806 | 30,634 |
| Net Cash Flow | $-7,184 | $-15,838 | $-17,919 | $-10,898 | $-5,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,184 | -25,222 | -17,811 | -10,797 | -5,040 |
| Capital Expenditure | 0 | -226 | -108 | -101 | -30 |
| Free Cash Flow | -7,184 | -25,448 | -17,919 | -10,898 | -5,070 |